These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 25634708)

  • 41. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications.
    Wolraich ML; Wibbelsman CJ; Brown TE; Evans SW; Gotlieb EM; Knight JR; Ross EC; Shubiner HH; Wender EH; Wilens T
    Pediatrics; 2005 Jun; 115(6):1734-46. PubMed ID: 15930238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Findings from the observational COMPLY study in children and adolescents with ADHD: core symptoms, ADHD-related difficulties, and patients' emotional expression during psychostimulant or nonstimulant ADHD treatment.
    Dittmann RW; Banaschewski T; Schacht A; Wehmeier PM
    Atten Defic Hyperact Disord; 2014 Dec; 6(4):291-302. PubMed ID: 24705867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response/remission with guanfacine extended-release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Cutler AJ; Brams M; Bukstein O; Mattingly G; McBurnett K; White C; Rubin J
    J Am Acad Child Adolesc Psychiatry; 2014 Oct; 53(10):1092-101. PubMed ID: 25245353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.
    Hart H; Radua J; Nakao T; Mataix-Cols D; Rubia K
    JAMA Psychiatry; 2013 Feb; 70(2):185-98. PubMed ID: 23247506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polypharmacy in the Management of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Review and Update.
    Baker M; Huefner JC; Bellonci C; Hilt R; Carlson GA
    J Child Adolesc Psychopharmacol; 2021 Apr; 31(3):148-163. PubMed ID: 33600217
    [No Abstract]   [Full Text] [Related]  

  • 47. Medications for adolescents with attention-deficit/hyperactivity disorder.
    Soileau EJ
    Adolesc Med State Art Rev; 2008 Aug; 19(2):254-67, viii-ix. PubMed ID: 18822831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacotherapy of attention-deficit hyperactivity disorder in adolescents.
    Childress AC; Berry SA
    Drugs; 2012 Feb; 72(3):309-25. PubMed ID: 22316347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents.
    Faraone SV; McBurnett K; Sallee FR; Steeber J; López FA
    Clin Ther; 2013 Nov; 35(11):1778-93. PubMed ID: 24139092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
    Sasané R; Hodgkins P; Meijer W
    Curr Med Res Opin; 2010 Nov; 26(11):2565-74. PubMed ID: 20863165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration.
    Newcorn JH; Stein MA; Childress AC; Youcha S; White C; Enright G; Rubin J
    J Am Acad Child Adolesc Psychiatry; 2013 Sep; 52(9):921-30. PubMed ID: 23972694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology of Treatment for Preschoolers on Kentucky Medicaid Diagnosed with Attention-Deficit/Hyperactivity Disorder.
    Davis DW; Feygin Y; Creel L; Kong M; Jawad K; Sun J; Blum NJ; Lohr WD; Williams PG; Le J; Jones VF; Pasquenza N
    J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):448-455. PubMed ID: 32614247
    [No Abstract]   [Full Text] [Related]  

  • 56. Attention-deficit/hyperactivity disorder in children and adolescents.
    Dunn DW; Kronenberger WG
    Neurol Clin; 2003 Nov; 21(4):933-40. PubMed ID: 14743657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attention deficit/hyperactivity disorder medication and dental caries in children.
    Rosenberg SS; Kumar S; Williams NJ
    J Dent Hyg; 2014 Dec; 88(6):342-7. PubMed ID: 25534686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of adjunctive guanfacine extended release on stimulant adherence in children/adolescents with attention-deficit/hyperactivity disorder.
    Meyers J; Gajria K; Candrilli SD; Fridman M; Sikirica V
    J Comp Eff Res; 2017 Mar; 6(2):109-125. PubMed ID: 28118752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical suggestions for management of stimulant treatment in adolescents.
    Weiss M; Jain U; Garland J
    Can J Psychiatry; 2000 Oct; 45(8):717-23. PubMed ID: 11086554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attention Deficit Hyperactivity Disorder in Athletes.
    Ciocca M
    Clin Sports Med; 2019 Oct; 38(4):545-554. PubMed ID: 31472765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.